Enhancement of Rhamnolipid Production in Residual Soybean Oil by an Isolated Strain of Pseudomonas aeruginosa

DE LIMA, C. J. B ; FRANCA, F. P ; SERVULO, E. F. C ; RESENDE, M. M ; CARDOSO, V. L

Heidelberg: Springer

Texto completo disponível

36258 New onset COVID-19 related thrombocytopenia in the immediate postpartum period: a case report

José Pedro Afonso ; Rita Gonçalves Cardoso ; Xavier, João ; Sampaio, Catarina

Secaucus: BMJ Publishing Group LTD

Texto completo disponível

AB1316 SAFETY AND IMMUNOGENICITY OF TWO HETEROLOGOUS VACCINE SCHEDULES AGAINST SARS-CoV-2 IN PATIENTS WITH RHEUMATOID ARTHRITIS: BRAZILIAN MULTICENTER STUDY

Cruz, V ; K Lysie Libardi Lira Machado ; Gonçalves Da Silva, V ; K Rosemarie Lallemand Tapia ; L Baptista Ferreira ; Neves Burian, A P ; Dias, L H ; C Strauss Estevez Gadelha ; Y Gurtler Pinheiro de Oliveira ; M Deorce de Lima ; L Pizzol Pasti ; Ribeiro de Oliveira, J ; Albertino, L Fiorotti ; De Oliveira Macabú, M ; Lorencini, P Zava ; V Oliveira Magalhães ; Freitas de Aguiar, M ; Biegelmeyer, E ; P Dias Cardoso Ribeiro ; F M Matos Melo Campos Peixoto ; Kayser, C ; A Wagner Silva de Souza ; C H D M Castro ; Ribeiro, S ; R Holanda Da Silva Sanches ; Boechat, A Luiz ; V Miki Pang Takatani ; C Ruas Yasuda ; D Queiroz Rego ; R Beatriz Nazareth Alagia ; R Teixeira Rebello ; Buhring, J ; Sartori, N ; N Pamplona Bueno de Andrade ; Gasparini Vieira, M L ; R Poubel Vieira de Rezende ; K Lino Baptista ; L Rodrigues Campos ; Melo, A K ; T Santos Melo ; Rêgo, J ; Vieira, R M R ; Rodrigues Vieira, A Sophia ; Kakehasi, A ; A C Faria Moreira Gomes Tavares ; Teixeira de Landa, A ; Dias Corrêa, M C ; Azevedo, V F ; O Assis Martins-Filho ; Peruhype-Magalhães, V ; Pinheiro, M ; Monticielo, O ; E Torres Dos Reis Neto ; Ferreira, G ; De Souza, V ; Teixeira-Carvalho, A ; Xavier, R ; Sato, E ; Valim, V ; Pileggi, G Salviato ; Da Silva, N

London: BMJ Publishing Group LTD

Texto completo disponível

POS0643 RITUXIMAB-ASSOCIATED HYPOGAMMAGLOBULINEMIA IN PATIENTS WITH RHEUMATIC DISEASES: A MULTICENTER RETROSPECTIVE OBSERVATIONAL STUDY

Rusinovich, O ; Calvo-Aranda, E ; Gomez Gonzalez, C M ; P Cardoso Peñafiel ; P Navarro Palomo ; Machattou, M ; Alonso de Francisco, M ; C Navarro Joven ; Navarro, P ; Moreira, M Cantalejo ; Diaz Oca, A J ; M Perez Ferro ; J B Polo Y La Borda ; V Garcia Garcia ; M Fernandez Castro ; Godoy, H ; C Merino Argumánez ; Garcia-Magallon, B ; C Barbadillo Mateos ; De Villa, L F ; C Isasi Zaragoza ; J Campos Esteban ; Andréu Sánchez, J L ; Sánchez-Alonso, F ; S Gonzalo Pascua ; Sanz, J

London: BMJ Publishing Group LTD

Texto completo disponível

Development of a patient-centered core outcome set for metastatic breast cancer

de Ligt, KM ; de Rooij, BH ; Hedayati, E ; Karsten, MM ; Smaardijk, VR ; Velting, M ; Saunders, C ; Travado, L ; Cardoso, F ; Ramirez, EL ; Carney, NC ; Wengstrom, Y ; Ives, A ; Velikova, G ; Fialho, MDLS ; Koppert, L ; Van de Poll-Franse, LV

Texto completo disponível

Neoadjuvant Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy Followed by Adjuvant Pembrolizumab vs Placebo for Early TNBC: Surgical Outcomes from the Phase 3 KEYNOTE-522 Study

Kummel, S ; Schmid, P ; Harbeck, N ; Takahashi, M ; Untch, M ; Boileau, JF ; Cortes, J ; McArthur, H ; Dent, R ; O'Shaughnessy, J ; Pusztai, L ; Foukakis, T ; Park, YH ; Hui, RN ; Cardoso, F ; Denkert, C ; Zhu, YL ; Pan, W ; Karantza, V ; Fasching, PA

Texto completo disponível

Pembrolizumab or placebo plus chemotherapy followed by pembrolizumab or placebo for early-stage TNBC: Updated EFS results from the phase III KEYNOTE-522 study

Schmid, P ; Cortes, J ; Dent, RA ; Pusztai, L ; McArthur, HL ; Kummel, S ; Denkert, C ; Park, YH ; Hui, R ; Harbeck, N ; Takahashi, M ; Foukakis, T ; Reynier, MAM ; Ferreira, MIR ; Im, SA ; Cardoso, F ; Ding, Y ; Pan, W ; Tryfonidis, KE ; O'Shaughnessy, J

Texto completo disponível

Multimodality Treatment and Survival in Sinonasal Minor Salivary Gland Tumors

Torabi, Sina J. ; Spock, Todd ; Cardoso, Bruno ; Chao, Janet ; Manes, R. Peter ; Judson, Benjamin L.

Stuttgart · New York: Georg Thieme Verlag KG

Texto completo disponível

Event-free survival by residual cancer burden after neoadjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for early TNBC: Exploratory analysis from KEYNOTE-522

Pusztai, L ; Denkert, C ; O'Shaughnessy, J ; Cortes, J ; Dent, RA ; McArthur, HL ; Kuemmel, S ; Bergh, JCS ; Park, YH ; Hui, RN ; Harbeck, N ; Takahashi, M ; Untch, M ; Fasching, PA ; Cardoso, F ; Zhu, YL ; Pan, W ; Tryfonidis, K ; Schmid, P

Texto completo disponível

HRQoL with neoadjuvant pembrolizumab plus chemotherapy vs placebo plus chemotherapy, followed by adjuvant pembrolizumab vs placebo for early-stage TNBC: Results from KEYNOTE-522

Dent, RA ; Cortes, J ; Pusztai, L ; McArthur, HL ; Kuemmel, S ; Bergh, J ; Denkert, C ; Park, YH ; Hui, R ; Harbeck, N ; Takahashi, M ; Untch, M ; Fasching, PA ; Cardoso, F ; Haiderali, A ; Jia, L ; Nguyen, AM ; Pan, W ; O'Shaughnessy, J ; Schmid, P

Texto completo disponível